Meeder Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75M | Sell |
6,176
-184
| -3% | -$81.9K | 0.14% | 110 |
|
|
2025
Q1 | $3.08M | Buy |
6,360
+753
| +13% | +$365K | 0.18% | 91 |
|
|
2024
Q4 | $2.26M | Sell |
5,607
-27
| -0.5% | -$10.9K | 0.14% | 118 |
|
|
2024
Q3 | $2.62M | Buy |
5,634
+62
| +1% | +$28.8K | 0.17% | 97 |
|
|
2024
Q2 | $2.61M | Buy |
5,572
+1,574
| +39% | +$738K | 0.18% | 87 |
|
|
2024
Q1 | $1.67M | Buy |
3,998
+325
| +9% | +$136K | 0.17% | 101 |
|
|
2023
Q4 | $1.49M | Buy |
3,673
+146
| +4% | +$59.4K | 0.17% | 98 |
|
|
2023
Q3 | $1.23M | Sell |
3,527
-584
| -14% | -$203K | 0.15% | 115 |
|
|
2023
Q2 | $1.45M | Buy |
4,111
+207
| +5% | +$72.8K | 0.16% | 111 |
|
|
2023
Q1 | $1.23M | Buy |
3,904
+225
| +6% | +$70.9K | 0.14% | 125 |
|
|
2022
Q4 | $1.06M | Buy |
+3,679
| New | +$1.06M | 0.13% | 147 |
|